Clinical Trial Update: Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Injection [Phase 1]

View source ↗

Summary

This is a Phase 1 safety and pharmacokinetics study in healthy male adults receiving repeated intravenous injections, sponsored by Green Cross Corporation, and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Investigational product

Snippet

Sponsor: Green Cross Corporation | Conditions: Hepatitis B | Phase 1 | Status: COMPLETED